Crossref
Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial
Yearbook of Paediatric Endocrinology · 30.09.2025
DOI: 10.1530/ey.22.10.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Tatovic D und 6 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
D, T., A, M., P, T., SJ, H., K, C., WY, C., & al, E. (2025). Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.10.2
Vancouver
D T, A M, P T, SJ H, K C, WY C, et al. Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.10.2
BibTeX
@article{D2025,
author = {D, Tatovic and A, Marwaha and P, Taylor and SJ, Hanna and K, Carter and WY, Cheung and al, et},
title = {Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial},
journal = {Yearbook of Paediatric Endocrinology},
year = {2025},
doi = {10.1530/ey.22.10.2}
}
EUVIMED